Lingga, Vanessa G.
HRN: 21-43-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 1.5GM (VIAL)
05/30/2022
06/05/2022
IVT
1.5g
Q8HRS
S/P LTCS Prophylaxis For Surgical Site Infection
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes